November/December 2009
IVD Technology
Selected Contents
Editor's Page
Richard Park
Molecular diagnostics offers great potential to the IVD industry, although significant barriers need to be addressed.
Trends & Perspectives
Molecular Diagnostics
Jonathan Siegrist, Régis Peytavi, Michel Bergeron, and Marc Madou
Despite extensive research on microfluidic nucleic acid IVDs, there are few, if any, such systems on the market.
Molecular Diagnostics
Using DNA in multiplexed detection schemes
Benjamin L. Miller and Randolph R. Henke
Various pursuits are ongoing to harness the advantages of DNA identification, yet there are many challenges still to be overcome to deliver such capabilities.
Assay Development
Automated quantitative microarray assay platforms
Peter Lea, Thomas E. T. O’Connor, Kate Smith, and Claude Ricks
A microarray-based assay platform has been developed for high test throughput, with a fully automated protocol.
Regulations & Standards
The Case for Regulating Laboratory-Developed Tests
Bradley Merrill Thompson and Leah R. Kendall
LDTs need regulation to prevent abuses and protect the public health.
In Person
Trends and advances in molecular diagnostics
Taking a quality systems approach to assay development, addressing re-emerging infectious threats, and dealing with resistant pathogens are keeping those in the molecular diagnostics industry very busy.
